Multiplexed immunohistochemistry using recombinant antibodies with epitope tags
The present disclosure is directed to epitope-tagged antibodies, as well as methods of employing the epitope-tagged antibodies for detecting one or more targets in a biological sample, e.g. a tissue sample.
1. A kit comprising:
(a) at least one epitope-tagged antibody, wherein the at least one epitope-tagged antibody comprises an antibody and at least one epitope tag construct, and
(b) detection reagents for detecting the at least one epitope-tagged antibody,
wherein the detection reagents comprise at least one anti-tag antibody, wherein the at least one anti-tag antibody is specific for an expressed epitope tag of the at least one epitope-tagged antibody, and
wherein the at least one epitope tag construct consists of the amino acid sequence selected from the group consisting of SEQ ID NO:16, SEQ ID NO:18, SEQ ID NO:20, SEQ ID NO:22, SEQ ID NO:24, SEQ ID NO:26, SEQ ID NO:28, SEQ ID NO:30, and SEQ ID NO:32.
2. The kit of claim 1 , wherein the at least one anti-tag antibody comprises a fluorophore.
3. The kit of claim 1 , wherein the at least one epitope-tagged antibody comprises at least one epitope-tagged antibody specific for FoxP3, at least one epitope-tagged antibody specific for CD8, at least one epitope-tagged antibody specific for CD68, at least one epitope-tagged antibody specific for CD3, and at least one epitope-tagged antibody specific for CD20.
4. The kit of claim 1 , wherein the at least one epitope tag construct is expressed at a terminal end of a heavy chain antibody.
5. The kit of claim 1 , wherein the at least one epitope-tagged antibody is specific for the antigen human FoxP3.
6. The kit of claim 5 , wherein the at least one epitope tag construct consists of the amino acid sequence of SEQ ID NO:22.
7. The kit of claim 1 , further comprising instructions for use.